证券代码：603031 股票简称：安孚科技 编号：2025-072 安徽安孚电池科技股份有限公司 关于签订募集资金专户存储三方监管协议的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金情况 经中国证券监督管理委员会（以下简称"中国证监会"）出具的《关于同意安徽安孚电池科技股份有限公 司发行股份购买资产并募集配套资金注册的批复》（证监许可〔2025〕1709号）同意，安徽安孚电池科 技股份有限公司（以下简称"公司"）向特定对象发行人民币普通股（A股）5,700,944股，发行价格为 35.79元/股，募集资金总额人民币204,036,785.76元，扣除不含税的发行费用人民币16,538,460.64元，公 司募集资金净额为人民币187,498,325.12元。 中证天通会计师事务所（特殊普通合伙）于2025年9月18日出具了《安徽安孚电池科技股份有限公司发 行股份及支付现金购买资产并募集配套资金验资报告》（中证天通（2025）验字21120005号）。 二、募集资金专户的开立及三方监管协议签订情况 为规范公 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 近日，金牌厨柜家居科技股份有限公司（以下简称为"公司"）及其泰国子公司金牌厨柜（泰国）有限责 任公司（GOLDENHOME(THAILAND)CO.,LTD.，以下简称"金牌泰国子公司"）与中国工商银行（泰 国）股份有限公司（以下简称"工商银行泰国公司"）、兴业证券股份有限公司（以下简称"兴业证券"） 签订了《募集资金专户存储三方监管协议》，相关内容公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准金牌厨柜家居科技股份有限公司非公开发行股票的批复》（证监 许可[2020]3578号）核准，公司向特定对象非公开发行人民币普通股(A)股10,017,513股,每股面值1.00元, 每股发行价格为人民币28.55元,募集资金总额为人民币285,999,996.15元，扣除与发行有关的费用（不含 税）人民币6,461,073.46元后,实收募集资金净额为人民币279,538,922.69元。华兴会计师事务所（特殊普 通合伙）对公司上述非公开发行股票的资金到位情况进行了审验，并于2021年6月18日出具华兴验字 [2021]21008640041号《验 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意安徽芯动联科微系统股份有限公司首次公开发行股票注册 的批复》(证监许可[2023]1012号)同意，安徽芯动联科微系统股份有限公司（以下简称"公司"或"芯动联 科"）首次向社会公开发行人民币普通股（A股）5,521万股。公司每股发行价格26.74元，新股发行募集 资金总额为147,631.54万元，扣除发行费用12,195.64万元后，募集资金净额135,435.90万元。中汇会计师 事务所(特殊普通合伙)对公司本次公开发行新股的资金到位情况进行了审验，并于2023年6月27日出具 了《安徽芯动联科微系统股份有限公司验资报告》（中汇会验[2023]8258号）。 募集资金到账后，已全部存放于经公司董事会批准开设的募集资金专项账户内，公司与保荐机构、存放 募集资金的银行签订了《募集资金专户存储三方监管协议》。 二、《募集资金专户存储三方监管协议》的签订情况和募集资金专户的开立情况 根据《上市公司募集资金监管规则》等相关规 ...

Core Points - The company has completed the implementation of the fundraising project for "supplementing working capital" and has a surplus of 26.8361 million yuan, which will be permanently used to supplement working capital [2][6] - The surplus funds will be used without the need for board approval or sponsor consent, and the usage will be disclosed in the annual report [2][3] - The company raised a total of 3.2975923 billion yuan from its initial public offering, with a net amount of 3.1941774 billion yuan after deducting issuance costs [3][4] Fundraising Basic Information - The China Securities Regulatory Commission approved the company's initial public offering on March 16, 2023, allowing the issuance of 501,153,847 shares at a price of 6.58 yuan per share [3] - The total amount raised was 3.2975923 billion yuan, with actual net proceeds of 3.1941774 billion yuan after deducting issuance expenses of 103.4149 million yuan [3] Fundraising Management - The company established a special account for fundraising to ensure proper management and usage, in compliance with relevant laws and regulations [4][5] - A four-party supervision agreement was signed with the bank and sponsor to oversee the usage of the funds [4] Cancellation of Fundraising Account - The fundraising account will be canceled after the surplus funds are fully utilized, for easier account management [6]

Group 1 - The company, Anhui Xindong Link Technology Co., Ltd., has announced the establishment of a special account for raised funds and signed a tripartite supervision agreement for the storage of these funds [1][4] - The company has successfully completed its initial public offering (IPO) of 55.21 million shares at a price of 26.74 RMB per share, raising a total of approximately 1.48 billion RMB, with a net amount of about 1.35 billion RMB after deducting issuance costs [2][3] - The funds raised will be allocated to the development and industrialization of the Inertial Measurement Unit (IMU) project, with the establishment of a corresponding special account approved by the board of directors [3][4] Group 2 - The tripartite supervision agreement involves the company, the Bank of Communications, and the underwriting institution, ensuring compliance with relevant regulations and protecting investors' rights [4][6] - The special account has been opened with a balance of 0 RMB as of September 19, 2025, and is exclusively for the IMU project, prohibiting any other use of the funds [6][10] - The underwriting institution is responsible for supervising the use of the raised funds, conducting at least biannual inspections, and ensuring compliance with the established management protocols [7][8]

Group 1 - The company has been approved to issue 145,132,743 shares at a price of RMB 5.65 per share, raising a total of approximately RMB 820 million, with a net amount of approximately RMB 802 million after deducting issuance costs [2][3] - The company has established a special account for the raised funds and signed a four-party supervision agreement with its subsidiary, the sponsor, and the bank to ensure proper management and usage of the funds [3][4] - The special account is designated solely for temporary liquidity support and cannot be used for any other purposes, ensuring compliance with regulatory requirements [3][5] Group 2 - The four-party supervision agreement includes provisions for monitoring the use of raised funds, requiring the sponsor to conduct semi-annual inspections and ensuring that any withdrawals exceeding RMB 50 million or 20% of the net raised funds are reported [5][6] - The agreement stipulates strict compliance with anti-corruption laws and regulations, prohibiting any party from soliciting or providing benefits outside the agreement [7][8] - The agreement will remain in effect until all funds are fully utilized and the account is legally closed, with any disputes to be resolved through arbitration in Shanghai [7][8]

Group 1 - The company has signed a tripartite supervision agreement for the storage of raised funds to ensure proper management and protection of investors' rights [2][3] - The company raised a total of RMB 129,000 million through a private placement of shares in August 2013, with a net amount of RMB 126,113.70 million after deducting issuance costs [1] - The company will allocate RMB 2,986 million from the remaining funds of a completed project to a new project focused on the information technology upgrade and efficiency enhancement of high-precision axle production lines [2] Group 2 - A special account for the raised funds has been established at the Bank of Communications, with a current balance of RMB 0 as of September 8, 2025, and the account is exclusively for the new project [3][4] - The agreement stipulates that the sponsor will supervise the use of the raised funds and can conduct on-site inspections and inquiries [4][5] - The company is required to notify the sponsor if withdrawals from the special account exceed 20% of the net amount of raised funds, which is RMB 25,222.74 million [4][5]

Group 1 - The company held its 30th meeting of the 9th Board of Directors on September 18, 2025, with all 13 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][4]. - The Board approved several proposals, including adjustments to the investment amounts for fundraising projects, the use of raised funds to replace self-raised funds for issuance expenses, and the management of idle raised funds [3][5][7]. - The adjustments to the investment amounts for fundraising projects were made to ensure the smooth implementation of these projects without changing the intended use of the funds [23][26]. Group 2 - The Supervisory Board also convened on September 18, 2025, with all 4 supervisors present, and approved similar proposals as the Board of Directors [15][17]. - The company plans to use up to 1.37 billion yuan of temporarily idle raised funds for cash management, ensuring that this does not affect the safety of the funds or the construction of investment projects [41][46]. - The cash management will involve low-risk, high-liquidity investment products, and the company aims to enhance the efficiency of fund usage and increase returns for shareholders [45][51].

Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. has received a warning letter from the China Securities Regulatory Commission (CSRC) due to violations in the management and use of raised funds, which included improper procedures and mixing of funds [1][2]. Group 1: Regulatory Findings - The Zhejiang Securities Regulatory Bureau found multiple issues in the management of raised funds, including failure to follow proper review procedures for fund replacement and using raised funds for unrelated expenses [1]. - The company was also found to have mixed raised funds with its own funds when purchasing structured deposit financial products [1]. Group 2: Accountability and Measures - Key executives, including the Chairman, General Manager, CFO, and Board Secretary, were held primarily responsible for the violations and received warning letters [2]. - The company and its executives are required to enhance their understanding of relevant laws and regulations, improve financial management practices, and ensure accurate and timely information disclosure [2]. Group 3: Company Response - The company has expressed its commitment to addressing the issues raised in the warning letter and implementing stricter controls over the use of raised funds [2]. - It emphasized that the regulatory measures will not affect its normal production and operations, and it will continue to fulfill its disclosure obligations [2].

近日，浙江仙琚制药股份有限公司收到浙江证监局出具的行政监管措施决定书〔2025〕210号。检查发 现，公司在募集资金管理和使用方面存在部分置换未按规定审议披露、支付无关费用、资金混同等问 题，董事长张宇松等4人对此承担主要责任。浙江证监局决定对公司及相关人员出具警示函并记入诚信 档案，要求10个工作日内提交书面报告。公司及相关人员表示将加强法规学习、切实整改，杜绝此类情 况再发生。本次监管措施不影响公司正常经营。 ...